Healthcare demand is outstripping supply in Noida, says MOFSL; prefers Medanta, Max HealthcareNoida-Greater Noida is rapidly becoming a prime healthcare hub in North India, fueled by population growth and corporate expansion. Despite...
27 Jun, 2026, 11.18 AM IST
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
26 Jun, 2026, 11.31 AM IST
Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
25 Jun, 2026, 05.34 PM IST
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...
25 Jun, 2026, 01.49 PM IST
Vishal Sikka’s AI startup Hang Ten Systems raises $32 million led by MayfieldFormer Infosys CEO Vishal Sikka has launched Hang Ten Systems, an AI startup focused on enterprise solutions, securing $32 million in seed ...
24 Jun, 2026, 08.52 PM IST
For investors who focus on the long term: 5 mid-cap stocks from different sectors with upside potential up to 28%When prices fall, caution comes naturally. Investors hesitate, portfolios are reviewed less often, and even optimists become careful. But w...
23 Jun, 2026, 05.42 PM IST
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
22 Jun, 2026, 12.25 PM IST
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
19 Jun, 2026, 11.50 AM IST
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
17 Jun, 2026, 03.08 PM IST
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
17 Jun, 2026, 09.44 AM IST
Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
16 Jun, 2026, 07.50 PM IST
Novartis India launches Pluvicto for prostate cancer treatmentNovartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...
15 Jun, 2026, 03.09 PM IST
India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
12 Jun, 2026, 11.48 PM IST
India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...
12 Jun, 2026, 11.02 AM IST
Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
11 Jun, 2026, 07.29 AM IST
$10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
10 Jun, 2026, 01.06 AM IST
- Promoters want to delist Fresenius Kabi Oncology from bourses
Fresenius Kabi (Singapore) Pte Ltd is planning to delist its Indian arm Fresenius Kabi Oncology by buying out 19 % stake held by the public.
17 Apr, 2013, 11.16 PM IST